Probiotic nutrients have shown promise in therapy for the treatment of gastrointestinal inflammation, infection, and atopic disease. Intestinal dendritic cells (DC) play a critical role in shaping the intestinal immune response. In this study, we tested the effect of a probiotic preparation (VSL#3) on DC distribution and phenotypes within the intestinal mucosa using a lineage depletion-based flow cytometric analysis. In naïve C57BL/10J mice, intestinal mucosal DC were composed of plasmacytoid DC (pDC) and myeloid DC (mDC). The pDC were the dominant form in lamina propria and Peyer's patches, whereas mDC were the prevailing type in the mesenteric lymph nodes. Additional characterization of pDC and mDC with flow cytometry revealed that they expressed heterogeneous phenotypes in the intestinal mucosa. In mice gavaged with the probiotic VSL#3 for 7 d, the proportion of pDC within the lamina propria was .60% lower, whereas the pDC subset in the mesenteric lymph nodes was more than 200% greater than in sham-treated controls (P , 0.01). Within pDC, the proportion of functionally unique CX3CR1 + DC was greater than in controls in both the lamina propria and the Peyer's patches (P , 0.01). In contrast to pDC, the mDC number was greater than in controls in all intestinal lymphoid tissue compartments in VSL#3-treated mice (P , 0.01). In conclusion, this study suggests that phenotypically and functionally distinct DC subsets are localized to specific lymphoid tissues within the intestinal mucosa and that the VSL#3 probiotic nutritional supplement alters the distribution of the DC subsets within the intestinal mucosa. These changes may be important in the alteration of mucosal immunity following probiotic VSL#3 therapy.
Introduction
As dietary constituents are processed in the lumen of the gastrointestinal tract, they are exposed to the intestinal immune system (1) . Dietary antigens that are captured by dendritic cells (DC) 7 in the intestinal mucosa are processed and presented to T-cells. The DC system is a complex and heterogeneous leukocyte population of professional antigen-presenting cells (2) . They are involved in orchestrating immune responses to foreign antigens while maintaining tolerance to self-antigens and allergens. DC are classified as myeloid DC (mDC) and plasmacytoid DC (pDC) (3) . Resting DC that capture self-antigens in the steady state are able to induce tolerance, whereas in the presence of inflammation, these same cells are able to initiate adaptive immune responses. There are several subsets of DC with functional differences among DC subtypes [reviewed in (4) ], including varying cytokine/chemokine secretion, toll-like receptor expression, and T cell-polarizing ability. Luminal contents interact with the various DC subsets in the intestinal mucosa. Evidence exists that nutrients and food antigens are able to alter DC phenotypes and behaviors (5) (6) (7) , suggesting that intestinal luminal contents are directly involved in modulating mucosal DC function.
It has been shown that specific DC subsets are involved in T cell priming (8) (9) (10) . Several studies have demonstrated that DC take up residence in the intestinal mucosa, particularly within Peyer's patches and the lamina propria (11) . Mucosal DC are major antigen-presenting cells with the capacity to process oral antigens in vivo. They provide a sentinel function, which allows sufficient defense against potential pathogens but restricts the immune response to nonpathogenic resident commensal bacteria and food antigens. Furthermore, a number of independent investigations revealed induction of mucosal tolerance in Peyer's patch deficient animals (12) (13) (14) , suggesting that DC in lamina propria may play an essential role in mucosal immunity.
Probiotics are live microorganisms, which confer benefits to the host when administrated in sufficient amounts (15) . They have been commonly used as nutritional or dietary supplements. A growing body of evidence suggests that administration of probiotics results in modulation of intestinal immunity, improvement of the balance of the gut microflora, enhancement of the recovery of the disturbed gut mucosal barrier, and prevention of microbial translocation [reviewed in (16, 17) ]. VSL#3, a probiotic preparation combining 8 different probiotic bacteria, has been shown to be effective at attenuating inflammatory bowel disease (18, 19) and preventing chemotherapy-induced diarrhea (20) . Recent studies suggest that DC functions may be modulated in vitro by VSL#3 probiotic (21) , Lactobacillus casei DN-114001 (22) , and supernatant from Bifidobacterium (23). However, the effect of VSL#3 probiotic therapy on intestinal DC phenotypes remains largely unknown. The aim of the present study was to characterize the intestinal DC subsets in C57BL/10J mice before and after feedings with probiotics.
Materials and Methods
Mice. Specific pathogen-free C57BL/6J and C57BL/10J mice (male, 8-12 wk old) were purchased from the Jackson Laboratory. They were housed in a specific pathogen-free animal facility at the Children's Memorial Research Center. All animal experiments were conducted in accordance with NIH guidelines under protocols approved by the Institutional Animal Care and Use Committee of the Children's Memorial Research Center.
Preparation of mononuclear cells from the small intestine. Five or 6 mice were used for each experiment. They were killed by CO 2 asphyxiation. The small intestine was washed extensively with saline and the fatty tissue, mesentery, and Peyer's patches were excised from intestinal segments. The entire intestinal tissue was cut open longitudinally and then cut into 3 pieces, which represented tissue segments of duodenum, jejunum, and ileum. They were processed for isolating mononuclear cells using a protocol modified from the method described by Niess et al. (24) . Briefly, each piece was washed with ice-cold calciumand magnesium-free PBS (CMF-PBS) containing 1 mmol/L dithiothreitol (Sigma Chemicals), treated with ice-cold CMF-PBS containing 30 mmol/ L EDTA for 30 s, and finally rinsed with ice-cold CMF-PBS (contain 0.75 mmol/L EDTA). Thereafter, intestines were cut into ,1-cm pieces and washed for 20-30 s in CMF-PBS containing 0.75 mmol/L EDTA (vigorously agitation). After rinsing with DMEM, the tissue pieces were treated for 45 min at 378C in humidified atmosphere containing 5% CO 2 with a DMEM-based enzyme cocktail that contains 36 kU/L collagenase IV (Sigma Chemicals), 150 mg/L DNase I (Roche), and 5% fetal bovine serum (FBS). In some experiments, Peyer's patches and mesenteric lymph nodes were digested with the enzyme-cocktail for 20 min. The undigested tissue debris was removed by filtration through a 100-mmpore size tissue sieve (Bioworld) followed by a second filtration through a 40-mm-pore size cell strainer (BD Falcon). Cells in the digestion buffer were further purified by centrifugation at 700 3 g; 8 min and washed twice with CMF-PBS containing 5% FBS, 5 mg/L DNaseI, and 5 mmol/L EDTA. The resulting cells were centrifuged through a 9.5% OptiPrep (r = 1055 g/L, Axis Shield) at 1700 3 g; 10 min to enrich for mononuclear cells. The mononuclear cell fractions were collected, washed, and immunostained with the antibody cocktails described below. The stained cells were subjected to acquisition and flow cytometric analysis.
Flow cytometry. Analysis of DC subsets was performed using fluorescein isothiocyanate-, phycoerythrin-, allophycocyanin-, peridinin chlorophyll protein-cyanine 5.5-, or phycoerythrin-cyanine 7-conjugated antibodies against CD11c (HL3), CD4 (RM4-5), CD8a (53-6.7), CD11b (M1/70), B220 (RA3-6B2), Ly6C (AL-21), CX3CR1 (ab8021), CD103 (M290), I-A/I-E (M5/114.15.2), and DEC-205 (NLDC-145). The staining cocktail for lineage-specific cell surface antigens contained biotin-conjugated anti-CD3, anti-CD19, and anti-F4/80 mAbs. Biotinylated antibodies were detected using streptavidin conjugated to APC. Murine cell-specific isotype-matched control Abs were used for the control staining to determine the background immunofluorescence. The above antibodies were purchased from BD Pharmingen, except for DEC205 and CX3CR1, which were obtained from Cedarlane and Abcam, respectively. Before staining, cells were preincubated with FCgIII/IIR antibody (2.4 G2) for 10 min on ice to block non-Fab antibody binding. After washing with PBS, cells (2 3 10 5 -5 3 10 5 ) were suspended in 100 mL of PBS containing 1% FBS, and appropriate antibodies. All staining was conducted for 40 min on ice in the dark. The resulting cells were analyzed using either a FACScalibur or FACS Aria (Becton Dickinson) cytometer. Data were analyzed with either CellQuest (Becton Dickinson) or FlowJo software (Tree Star).
Characterization of DC subsets with flow cytometry. The lineage depletion strategy described by Shortman et al. (25, 26) was used for identifying of DC. Briefly, the criteria outlined in Table 1 were used for characterizing DC phenotypes in the intestinal mucosa. DC subsets were further defined by staining mononuclear cell preparations with classical DC marker panels ( Table 2 ). To determine the DC functional and gutassociated characteristics, cells were stained with an antibody cocktail that contained antibodies against CX3CR1, CD103, DEC205, B220, CD11c, and lineage markers. Antibodies were conjugated with appropriate fluorochromes or biotin. All immunostained cells were subjected to flow cytometric analysis. 
CD19
2 F4/80 2 unbound mononuclear cells. The latter negatively selected cells were washed with PBS then stained with the cocktail of mAbs against DC subset-specific antigens described above. The stained cells were acquired and analyzed by flow cytometry.
Administration of probiotics VSL#3. VSL#3 is a medical food probiotic supplement that contains 4 lactobacilli, 3 bifidobacteria, and 1 streptococcal strain. In this study, mice were gavaged with PBS or probiotics VSL#3 (11.25 3 10 9 bacteria/(100 mg VSL#3 3 mouse), suspended in 200 mL PBS) on a daily basis for 7 d. At the end of the treatment, mice were killed by CO 2 inhalation. Mononuclear cells in lamina propria, Peyer's patches, and mesenteric lymph nodes were harvested and processed and purified for immunostaining as described above and then examined by flow cytometry.
Statistical analysis. All the experiments were performed at least twice. Data were tested by 1-way ANOVA and, where appropriate, post hoc Tukey-Kramer multiple comparison tests. Differences were considered significant at P , 0.05. The results were reported as means 6 SEM.
Results
Identification of lamina propria DC subsets in naïve C57BL/6J and C57BL/10J mice. Because murine DC are a 
CD11c
int/+ mononuclear cell population, we measured the level of CD11c expression on the surface of mononuclear cells isolated from lamina propria of C57BL/6J and C57BL/10J mouse strains. In C57BL/6J mice, 0.67 6 0.06% of the intestinal lamina propria mononuclear cells were positive for CD11c (Supplemental Fig. 1A ). In contrast, 5.87 6 0.12% of the lamina propria mononuclear cells isolated from C57BL/10J mice expressed CD11c (Supplemental Fig. 1B) . As the yield of lamina propria CD11c + cells in C57BL/6J mice was lower (P , 0.05) than the cells in C57BL/10J mice, we decided to use C57BL/10J mice in this study.
Typically, DC were a Lin 2 mononuclear cell population that acquired a characteristic of CD11c int/+ and I-A/I-E 2/+ (Supplemental Fig. 2) .
To phenotype DC, we used the criteria stated in Table 1 (Fig. 1A) . The mDC expressed a higher level of MHCII molecular (i.e. I-A/I-E) on their surface compared with pDC (Fig. 1B) . The majority of lamina propria Lin 2 I-A/I-E 2/+ CD11c int/+ cells were positive for B220 (Fig. 1C) , indicating that the pDC are the dominant form of DC in the lamina propria. The lamina propria CD11c int B220
+ Lin 2 mononuclear cells also expressed Ly6C (Fig. 1D) , which is consistent with the pDC characteristic (27) .
Characterization of DC subsets in lamina propria. In laminar propria, pDC (Lin 2 CD11c int B220 + Ly6C + ) expressed low to intermediate CD8a (Fig. 2A) . In contrast, mDC were negative for CD8a, contained CD11b + and CD11b 2 subsets, and were negative for CD4 (Fig. 2B) . Overall, the data indicated 2 subsets. Furthermore, we analyzed lamina propria DC in each intestinal fragment, because it was unclear whether intestinal DC distribution patterns are segment specific. DC were present in duodenum, jejunum, and ileum (Supplemental Fig. 3 ). The distribution of lamina propria DC subsets within each segment in C57BL/10J mice did not differ (Supplemental Fig. 3 ).
Relative distribution of lamina propria DC subsets vs. Peyer's patches and mesenteric lymph nodes in C57BL/ 10J mice. DC are present in various compartments of the intestinal mucosa, including lamina propria, Peyer's patches, and mesenteric lymph nodes. Therefore, we analyzed the relative distribution of DC subsets in the gut mucosa. The pDC subset was dominant in both laminar propria (Figs. 3A and 4) and Peyer's patches (Figs. 3B and 4) . The mDC, however, were the predominant subset within the mesenteric lymph node DC populations (Figs. 3C and 4) .
Expression of function-and gut-associated surface markers on the DC subsets within the gut mucosa of C57BL/10J mice. The expression of a DC functional associated marker (i.e. DEC205) and gut-associated markers (i.e. CX3CR1 and CD103) were further measured on the DC isolated from laminar propria, Peyer's patches, and mesenteric lymph nodes. The pDC in all 3 compartments were negative for DEC205 (Figs.  3 and 5A) , whereas a large proportion of mucosal mDC expressed DEC205 (Figs. 3 and 5B). Both pDC and mDC were heterogeneous positive for CD103 in lamina propria (Figs. 3A and 5) and Peyer's patches (Figs. 3B and 5) . In mesenteric lymph nodes, all pDC were negative for CD103 (Figs. 3C and 5A ), whereas~80% of mDC were positive for CD103 (Figs. 3C and 5B ).
Previous studies suggested that CX3CR1 is a unique functional marker for intestinal DC (24, 28) . Therefore, we precisely analyzed CX3CR1 expression on the DC surface in the intestinal mucosa. In the lamina propria, pDC were composed of CX3CR1 2 and CX3CR1 + subsets (Figs. 3A and 5A ). Among them, CX3CR1 2 cells were the predominant subset within the lamina propria pDC populations in naïve C57BL/10J mice. However, all pDC were negative for CX3CR1 in Peyer's patches (Figs. 3B and 5A) and mesenteric lymph nodes (Figs. 3C and  5A ). The mDC resident in all locations of the intestinal mucosa were negative for CX3CR1 (Figs. 3 and 5B).
Alterations in the distribution of intestinal mucosal DC subsets after administration of VSL#3 probiotic preparation. In C57BL/10J mice gavaged with VSL#3 probiotic for 7 d, the proportion of the pDC phenotype within the lamina propria was more than 60% less than in sham-treated controls (P , 0.05) (Fig. 6A,D) , whereas the pDC subset within the mesenteric lymph nodes was more than 200% greater (P , 0.05) (Fig. 6C,  D) . However, administration of probiotic VSL#3 did not alter the number of pDC in Peyer's patches (Fig. 6B,D) . Treatment with probiotic VSL#3 significantly increased the percentage of mDC in all intestinal mucosal tissues compared with the shamtreated group (Fig. 6 ). In addition, the number of CX3CR1 + pDC was also significantly higher in the VSL#3 probiotic-fed mice in lamina propria pDC and Peyer's patches in the controls ( Fig. 7 and Supplemental Fig. 4 ). This change is not associated with alteration of surface expression of CD103 (Supplemental Fig. 4) . Administration of VSL#3 did not affect the expression of DEC205 on the pDC surface in the intestinal lamina propria, Peyer's patches, and mesenteric lymph nodes (Supplemental Fig.  4) . In addition, feeding mice VSL#3 did not affect the expression of DC functional markers on the mDC surface in the intestinal lamina propria, Peyer's patches, and mesenteric lymph nodes (Supplemental Fig. 5 ).
Discussion
DC are present in the intestinal microenvironments. They constantly communicate with gut luminal contents such as food components, nutrients, and bacterial flora, which are an important determinant of immunity and immune responses. Previous studies demonstrated that nutrients such as vitamin A and its bioactive metabolite directly modulate the DC development and adhesion (5, 29) . Furthermore, the VSL#3 probiotic preparation or numerous Lactobacillus species have been shown to alter phenotype, cytokine release, and functions of DC in vitro (21, 30, 31) . Recent investigations revealed that feeding with a probiotic strain Lactobacillus paracasei subsp. paracasei NTU 101 (32) or the probiotic bacteria strain L. casei DN-114001-fermented milk (22, 33) resulted in upregulation of the antigenpresenting ability of DC. In the present study, we showed that administration of VSL#3 probiotic nutrient supplement results in a dramatic decrease in the proportion of pDC within the lamina propria, whereas the pDC subset increased significantly within the mesenteric lymph nodes. In contrast to pDC, the proportion of mDC significantly increased in intestinal lamina propria, Peyer's patches, and mesenteric lymph nodes after treatment with VSL#3 probiotic. Together, our results, in conjunction with previous research, suggest that administration of probiotics alters the distribution of DC subsets within the intestinal mucosa. Therefore, we hypothesize that probiotic supplements and microbial nutrients are able to reprogram intestinal DC.
In addition to examining the effect of VSL#3 probiotic treatment on intestinal DC physiology, we also characterized lamina propria DC of C57BL/10J mice here. We found that pDC (Lin 2 CD11 int B220 + Ly6C + ) is the dominant population of DC within the lamina propria in C57BL/10 mice. Furthermore, we found that lamina propria DC express a range of levels of CD8, CD11b, CD103, DEC205, and CX3CR1. Therefore, DC are highly heterogeneous within lamina propria in steady-state C57BL/10J mice. The function of DC is in a subset-dependent manner (34) (35) (36) (37) (38) . pDC induce CD4 + CD25 + T regulatory cells (39) and provide intrinsic protection against inflammatory responses to harmless antigens (40) . Recently, Goubier et al. (41) revealed that pDC mediate oral tolerance. In addition, CD103 + DC mediate induction of Foxp3 + Treg cells (36, 37) . Mucosal steady-state CD11b + mDC secrete interleukin-10 and promote Th2 differentiation, whereas the CD11b 2 mDC subset produces interleukin-12p70 upon bacterial stimulation and induces the Th1 response in naive TCR transgenic CD4 + T cells in vitro (38) . Thus, we speculate that lamina propria DC play multiple roles in maintaining immune homeostasis in the intestinal mucosa.
Previous studies suggest that CX3CR1 is an important surface marker associated with the function of mucosal DC. The expression of CX3CR1 leads to DC interacting with intestinal epithelial cells and extending dendrite to the lumen (24) . CX3CR1 may play a role in altering the adhesive properties of DC to intestinal epithelium (28) . In the present study, we demonstrated that lamina propria pDC are composed of CX3CR1 + and CX3CR1 2 populations and CX3CR1 2 DC are dominant at the lamina propria site in C57BL/10J mice. In + pDC subset in lamina propria and Peyer's patches. Together, our finding suggests that: 1) only a few lamina propria pDC are involved in directly sampling luminal antigens in C57BL/10J mice; 2) all intestinal mDC as well as most pDC in C57BL/10J mice do not directly contact intestinal epithelia or extend their dendrites to the intestinal lumen under the steady state; and 3) treatment with probiotics may promote pDCforming transepithelial dendrites, which may facilitate the cell contacting luminal antigens.
Besides the major findings stated above, we used the lineage depletion strategy described by Vremec and Shortman (25, 26) in the present work. To our knowledge, this is the first time that the lineage depletion strategy has been used to analyze DC phenotypic features in the murine intestinal mucosa. The phenotypic characterization of intestinal DC is involved in preparation of lamina propria mononuclear cells from the mucosal tissue, labeling cells with a range of surface markers followed by analysis of them with the flow cytometry. Intestinal lamina propria mononuclear cells are a mixed population containing T cells, B cells, macrophages, DC, and many other cells. CD11c can be used as a marker to label DC in the lamina propria mononuclear cell prep. However, it is not a unique marker for DC, because several non-DC lineage cells may also express CD11c. Thus, applying the lineage depletion strategy allows us to more precisely gain insight into phenotypic characteristics of DC in the intestinal mucosa.
Finally, Chirdo et al. (42) reported that lamina propria DC in inbred BALB/c mice are mainly composed of the CD11c + CD8a + MHCII + phenotype. In addition, Niess et al. (24) demonstrated that the CX3CR1-expressing DC population in the intestinal lamina propria express CD11b in inbred BALB/c mice and is thus of myeloid origin in this strain. In contrast, we found that pDC rather than mDC are dominant in lamina propria of inbred C57BL/10J mice. CX3CR1-expressing lamina propria DC are derived from plasmacytoid origin in inbred C57BL/10J mice. In addition, we have shown that lamina propria in C57BL/10J mice have more DC than in C57BL/6J mice. Our result is consistent with a previous report indicating that~0.5-1% the lamina propria mononuclear cells in C57BL/ 6J mice were CD11c + cells (43) . By comparing data obtained from the inbred C57BL mice in the present study to results from BALB/c mice reported by other investigators, we speculate that different inbred mouse strains exhibit differences in the DC distribution pattern and phenotypic characteristics in the intestinal mucosa. The data reported by Asselin-Paturel et al. (27) further support this hypothesis. However, it remains to be determined whether the mouse strain-based differences in intestinal mucosal DC characteristics are physiological meaningful. In the summary, we characterized the intestinal lamina propria DC subsets in C57BL/10J mice and compared them with DC in Peyer's patches and mesenteric lymph nodes in this study. Furthermore, we investigated the effect of VSL#3 probiotic therapy on DC phenotypes in the intestinal mucosa. We found that lamina propria DC isolated from naïve C57BL/10J mice have unique phenotypic characteristics, which differ from previously reported lamina propria DC phenotype in BALB/c mice (42) . In addition, we found that exposure to VSL#3 probiotic causes a shifting DC distribution within intestinal mucosa in both lymphoid tissue compartment and DC subsetdependent mechanisms. We speculate that the action of probiotic VSL#3 on DC physiology influences immune responses in the intestinal mucosa.
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